Figure 3.
Jitter plot showing subjects who were NAb negative (top) and NAb positive (bottom) by dose and treatment cycle for each approved indication (≈95% of subjects received 1–9 treatment cycles; no subject was positive beyond treatment cycle 9).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.